Search This Blog

Translate

Showing posts with label erectile dysfunction. Show all posts
Showing posts with label erectile dysfunction. Show all posts

Wednesday, July 3, 2013

High Blood Pressure Medications and Erectile Dysfunction: Felodipine+ Irbesatan Compared to Felodipine+ Metopronol

The combination of a calcium channel blocker (felodipine) with an ACE II inhibitor (irbesartan) is better than combining felodipine with a beta blocker (metoprolol)


 2013 Jun 26;125(4):235-241. [Epub ahead of print]

The Effect of Combined Antihypertensive Treatment (Felodipine with Either Irbesartan or Metoprolol) on Erectile Function: A Randomized Controlled Trial.

Source

Department of Cardiology, the Second Hospital of Lanzhou University, Lanzhou, China.

Abstract

Objectives: This study aimed to determine whether combining a calcium channel blocker with either an angiotensin II receptor blocker or a β-blocker would have similar effects on sexual function in men with hypertension. Methods: This prospective, randomized study (ClinicalTrials.gov: NCT01​238705) included 218 male participants with untreated hypertension. Patients were randomized to treatment with felodipine combined with irbesartan or metoprolol for 48 weeks. Sexual function was evaluated at baseline and after 48 weeks of therapy. The levels of serum sex hormones and markers of oxidative stress were measured at the same time. Results: There was no significant difference in the prevalence of erectile dysfunction before and after treatment in either group (p > 0.05). There were also no differences in the levels of serum testosterone, sex hormone-binding globulin or 4-hydroxynonenal before and after treatment in either group (p > 0.05). In the felodipine-irbesartan group, sexual desire scores rose after treatment (p = 0.022) and the concentrations of serum 8-hydroxy-2'-deoxyguanosine and malondialdehyde declined (p < 0.001 and p = 0.002, respectively). The between-group differences for 8-hydroxy-2'-deoxyguanosine and malondialdehyde were not significant (p > 0.05, respectively). Conclusion: The results suggest that felodipine-irbesartan may be more beneficial to the sexual desire of hypertensive male patients than felodipine-metoprolol. This effect was possibly relevant to irbesartan, which prevents oxidative stress to some extent.

Friday, May 4, 2012

How to Avoid Getting Man Boobs


From the book: Testosterone: A Man's Guide


Avoiding Enlarged Breast (Gynecomastia)


Yes, I am talking about breast appearance in men, not women. Gynecomastia is a benign enlargement of the male breast resulting from a growth of the glandular tissue of the breast. It is defined clinically by the presence of a rubbery or firm mass extending concentrically from the nipples. Men who start experiencing this problem complain of pain and tenderness around the nipple area. Gynecomastia is caused by higher than normal blood levels of estradiol, a metabolite of estrogen. As discussed earlier in the book, testosterone can convert into estradiol, DHT, and other metabolites. Men with higher amounts of the enzyme aromatase usually have this problem even at lower doses of testosterone. Growth of this glandular tissue is influenced by a higher fat percentage, older age, excessive alcohol intake, and the use of certain medications. Gynecomastia usually occurs early in testosterone replacement in those who experience this side effect.

In several studies on testosterone replacement, only a very small percentage of people receiving testosterone experience growth of breast tissue. In one HIV-specific study conducted by Dr. Judith Rabkin in New York, she reported that out of 150 men enrolled in the study, two men experienced this adverse reaction. Gynecomastia is much more common among those who use high testosterone doses, such as bodybuilders (they call this "gyno" or "bitch-tits").
How do you manage gynecomastia if it does occur? Lowering the testosterone dose had not proven helpful for the two patients in Dr. Rabkin’s study. The use of antiestrogens, such as tamoxifen 10 mg twice daily, with lower doses of testosterone has been effective. Gynecomastia can become permanent if the condition lasts very long although it may reduce in size when the androgen use is discontinued. In the absence of resolution, surgical correction may be necessary in severe cases.

For men who experience enlarged breast size, doctors usually check estradiol levels to determine whether too much testosterone is being converted into estrogen. I do not believe that routine measurement of estrogen is needed for men who have no symptoms of high estrogen (mainly breast tissue enlargement and water retention). For those who have higher than normal estrogen, doctors usually prescribe an antiestrogen medication. One such regimen is anastrozole at 1 mg/day during the first week until nipple soreness and breast enlargement disappear. The dose is then lowered to 0.25 mg a day, or 1 mg twice a week.

A warning: Bringing estrogen down to very low levels could cause health problems in men in the long run. Hair/skin quality and health, brain function, bone density, and other important factors may be greatly influenced by estrogen. However a 12-week study in men using anastrozole at 1 mg a day and 1 mg twice a week found no changes in bone metabolism markers.

The normal production ratio of testosterone to estrogen is approximately 100:1. The normal ratio of testosterone to estrogen in the circulation is approximately 300:1. Estrogen (measured as estradiol) should be kept at 30 picograms per milliliter (pg/mL) or lower. As men grow older or as they gain a lot of fat mass, their estrogen blood levels increase, even to levels higher than that of postmenopausal women.

Medications and Products That Can Cause Gynecomastia
A number of medications have been reported in the medical literature to cause gynecomastia due to decreases in testosterone, increases in estradiol, or both. These include:
  • Antiandrogens. These include cyproterone, flutamide, and finasteride.used to treat prostate cancer and some other conditions.
  • HIV medications. Sustiva, Atripla, and Videx have been associated with gynecomastia.
  • Anti-anxiety medications such as diazepam (Valium).
  • Tricyclic antidepressants. These include amitriptyline.
  • Glucocorticoid steroids.
  • Antibiotics.
  • Ulcer medication such as cimetidine (Tagamet).
  • Cancer treatment (chemotherapy).
  • Heart medications such as digitalis and calcium channel blockers.
  • Anabolic steroids
Substances that have been reported to cause gynecomastia include:
  • Alcohol
  • Amphetamines
  • Marijuana
  • Heroin
  • Soy and flaxseed- There are conflicting studies but it is something to keep in mind
  • Exposure to pesticides and byproducts of plastic processing has also been linked to increased estrogen and decreased sperm count in men.
For more information on anastrozole pricing by prescription, fill out this form: Click Here

Monday, April 9, 2012

What Should Be the Cut-Off Total Testosterone Blood Level for Men with Diabetes?

Diabetes mellitus is a common chronic disease, affecting 0.5–2% worldwide. The Massachusetts Male Aging Study reported that up to 75% of men with diabetes have a lifetime risk of developing ED. Type 2 diabetes is associated with low total serum testosterone (TT) identified in several cross-sectional studies and systemic analyses. There is a lack of consensus regarding what constitutes the lowest level of testosterone within the boundaries of normality.


This study proposes a cut-off value of 403.5 ng/dl of TT blood levels as an indicator for initiation of testosterone replacement therapy in diabetic men with ED.

Saturday, June 25, 2011

The Effect of Antihypertensive Drugs on Erectile Function: A Proposed Management Algorithm - By Michael Doumas MD, Stella Douma

Blood pressure medications are one of the main culprits of erectile dysfunction in men who are aging. This is a great review of medications and algorithm . Too bad that it does not include the use of testosterone in that algorithm!

CLICK HERE

Register in our new forum site